CLINICAL IMPACT OF DEPRESSION ON TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS: A LITERATURE REVIEW

Authors

DOI:

https://doi.org/10.31435/ijitss.2(50).2026.5230

Keywords:

Arthritis, Rheumatoid, Depression, Treatment Outcome, Medication Adherence, Patient Reported Outcome Measures

Abstract

Depression is a common comorbidity in rheumatoid arthritis, however we still don't know enough about how it affects treatment outcomes. This systematic review aims to assess the clinical influence of depression on disease activity, remission rates, pharmacological treatment response, patient-reported outcomes, and treatment adherence behaviour in individuals with rheumatoid arthritis. A thorough literature review was performed using PubMed, Scopus and Web of Science. We focused on studies published from 2020 to 2026 that evaluated depressive symptoms through validated instruments and reported at least one treatment-related outcome. The results consistently indicated that comorbid depression correlated with greatly elevated composite disease activity scores. It was mostly influenced by subjective rather than objective components. Patients exhibiting depressive symptoms were less likely to attain remission and demonstrated diminished responses to both conventional synthetic and biologic disease-modifying antirheumatic drugs. Depression was also found to be a strong independent predictor of worse health-related quality of life, more pain, more functional disability and less adherence to treatment. These findings underscore the necessity for regular depression screening in rheumatology practice and advocate for the incorporation of mental health interventions into the management of rheumatoid arthritis to enhance treatment outcomes.

References

Fakra, E., & Marotte, H. (2021). Rheumatoid arthritis and depression. Joint Bone Spine, 88(5), Article 105200. https://doi.org/10.1016/j.jbspin.2021.105200

Ionescu, C. E., Popescu, C. C., Agache, M., Dinache, G., & Codreanu, C. (2022). Depression in rheumatoid arthritis: A narrative review—Diagnostic challenges, pathogenic mechanisms and effects. Medicina, 58(11), Article 1637. https://doi.org/10.3390/medicina58111637

Dagli, A., Lee, R. R., & Bluett, J. (2024). The effect of depression on disease activity and treatment response in patients with inflammatory arthritis: Results from a narrative literature review. Neuropsychiatric Disease and Treatment, 20, 1377–1386. https://doi.org/10.2147/NDT.S456231

Zhang, L., Cai, P., & Zhu, W. (2020). Depression has an impact on disease activity and health-related quality of life in rheumatoid arthritis: A systematic review and meta-analysis. International Journal of Rheumatic Diseases, 23(3), 285–293. https://doi.org/10.1111/1756-185X.13774

Matcham, F., Ali, S., Irving, K., Hotopf, M., & Chalder, T. (2016). Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskeletal Disorders, 17, Article 155. https://doi.org/10.1186/s12891-016-1011-1

Giblon, R. E., Achenbach, S. J., Myasoedova, E., Davis, J. M., III, Kronzer, V. L., Bobo, W. V., & Crowson, C. S. (2025). Trends in anxiety and depression among individuals with rheumatoid arthritis: A population-based study. The Journal of Rheumatology, 52(3), 210–218. https://doi.org/10.3899/jrheum.2024-0165

Ionescu, C. E., Popescu, C. C., Agache, M., Dinache, G., & Codreanu, C. (2024). Depression in rheumatoid arthritis: Prevalence and effects on disease activity. Journal of Clinical Medicine, 13(7), Article 2058. https://doi.org/10.3390/jcm13072058

Ionescu, C. E., Popescu, C. C., & Codreanu, C. (2025). Impact and prevalence of depression and anxiety in rheumatoid arthritis—A cross-sectional study with self-reported questionnaires. Journal of Clinical Medicine, 14(5), Article 1718. https://doi.org/10.3390/jcm14051718

Pham, H. T., Vu-Thi, H., Le, C. T., Dau, Q. L., Nguyen, M. D., & Nguyen-Van, H. (2024). Characteristics of depressive disorders in patients with rheumatoid arthritis and some related factors. European Review for Medical and Pharmacological Sciences, 28(1), 255–262. https://doi.org/10.26355/eurrev_202401_34911

Fragoulis, G. E., Cavanagh, J., Tindell, A., Derakhshan, M., Paterson, C., Porter, D., McInnes, I. B., & Siebert, S. (2020). Depression and anxiety in an early rheumatoid arthritis inception cohort: Associations with demographic, socioeconomic and disease features. RMD Open, 6(3), Article e001376. https://doi.org/10.1136/rmdopen-2020-001376

Khadour, F. A., Khadour, Y. A., & Ebrahem, B. M. (2024). A qualitative survey on factors affecting depression and anxiety in patients with rheumatoid arthritis: A cross-sectional study in Syria. Scientific Reports, 14(1), Article 11513. https://doi.org/10.1038/s41598-024-61523-3

Snoeck Henkemans, S. V. J., Vis, M., Koc, G. H., Luime, J. J., Kok, M. R., Tchetverikov, I., van der Kooij, S. M., Bijsterbosch, J., van der Helm-van Mil, A. H. M., & de Jong, P. H. P. (2025). Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis. Rheumatology, 64(5), 2411–2421. https://doi.org/10.1093/rheumatology/keae621

Citera, G., Jain, R., Irazoque, F., Madariaga, H., Gruben, D., Wang, L., Stockert, L., Santana, K., Ebrahim, A., & Ponce de Leon, D. (2024). Tofacitinib efficacy in patients with rheumatoid arthritis and probable depression/anxiety: Post hoc analysis of phase 3 and 3b/4 randomized controlled trials. Rheumatology and Therapy, 11(1), 35–50. https://doi.org/10.1007/s40744-023-00612-7

Tański, W., Szalonka, A., & Tomasiewicz, B. (2022). Quality of life and depression in rheumatoid arthritis patients treated with biologics: A single centre experience. Psychology Research and Behavior Management, 15, 491–501. https://doi.org/10.2147/PRBM.S352984

Rojas-Gualdrón, D. F., Franco-Salazar, C., Gómez-Henck, C. Á., Manrique-Castrillón, M. C., Hoyos-Méndez, Y. C., Vélez-Romero, S., & Díaz-Coronado, J. C. (2024). Health-related quality of life loss associated with self-perceived anxiety/depression in seropositive rheumatoid arthritis. Clinical Rheumatology, 43(12), 3647–3655. https://doi.org/10.1007/s10067-024-07186-x

Alwhaibi, M. (2025). Depression, anxiety, and health-related quality of life in adults with rheumatoid arthritis: Findings from a national survey. Journal of Clinical Medicine, 14(22), Article 7940. https://doi.org/10.3390/jcm14227940

Abdelrahman, M. S. I., Shaddad, A. M., Khaleel, W. G. E., et al. (2024). Sleep quality, anxiety, depression, and quality of life in rheumatoid arthritis patients and impact of disease activity. Egyptian Rheumatology and Rehabilitation, 51, Article 10. https://doi.org/10.1186/s43166-024-00242-z

Rizaj, D., & Kelmendi, A. (2024). Quality of life, depression, and psychological distress among patients with rheumatoid arthritis treated with biologics. Cureus, 16(10), Article e72384. https://doi.org/10.7759/cureus.72384

Zhang, L., Zhu, W., & Liu, S. (2025). Psychological interventions for reducing depressive symptoms in rheumatoid arthritis patients: A systematic review and network meta-analysis. Psychology, Health & Medicine, 30(9), 1867–1885. https://doi.org/10.1080/13548506.2025.2482949

Downloads

Published

2026-04-27

How to Cite

Błaszczak, M., Leja, W. ., Latalska, K. ., Zulfiqar, Z. ., Kot, J., Czechowicz, K. ., Szczupaj, M. ., Pastuszak , A. ., Borkowski , K., & Rudnicki , J. . (2026). CLINICAL IMPACT OF DEPRESSION ON TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS: A LITERATURE REVIEW. International Journal of Innovative Technologies in Social Science, 1(2(50). https://doi.org/10.31435/ijitss.2(50).2026.5230

Most read articles by the same author(s)